Optimizing spot-scanning proton arc therapy with a novel spot sparsity approach

被引:0
|
作者
Fan, Qingkun [1 ]
Zhao, Lewei [2 ]
Li, Xiaoqiang [3 ]
Qian, Yujia [4 ]
Dao, Riao [4 ]
Hu, Jie [1 ]
Zhang, Sheng [5 ,6 ]
Yang, Kunyu [5 ,6 ]
Lu, Xiliang [1 ]
Yang, Zhijian [1 ]
Ding, Xuanfeng [3 ]
Dai, Shuyang [1 ,6 ]
Liu, Gang [5 ,6 ]
机构
[1] Wuhan Univ, Sch Math & Stat, Wuhan, Peoples R China
[2] Stanford Univ, Dept Radiat Oncol, Stanford, CA USA
[3] Corewell Hlth William Beaumont Univ Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA
[4] Wuhan Univ, Sch Phys & Technol, Wuhan, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[6] Hubei Key Lab Precis Radiat Oncol, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
delivery efficiency; proton arc therapy; spot number; OPTIMIZATION; ROBUST;
D O I
10.1002/mp.17517
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundOne of the main challenges of utilizing spot-scanning proton arc therapy (SPArc) in routine clinics is treatment delivery efficiency. Spot reduction, which relies on spot sparsity optimization (SSO), is crucial for achieving high delivery efficiency in SPArc.PurposeThis study aims to develop a novel SSO approach based on the alternating directions method of multipliers (ADMM) for SPArc to achieve high treatment delivery efficiency and maintain optimal dosimetric plan quality.MethodsIn this study, SSO for SPArc is based on the least-square dose fidelity term with L0-norm regularization. The novel optimization approach is based on the ADMM framework, in which the minimum monitor unit constraint was considered to improve the plan quality. A state-of-the-art SSO method, the primal-dual active set with continuation (PDASC) algorithm published previously, was utilized as a benchmark. Two SPArc plan groups with the same beam assignment and clinical constraint were generated, in which the former group was SPArc plan with SSO utilizing ADMM, denoted as SPArcADMM$\text{SPArc}_{\text{ADMM}}$, and the later group was SPArc with SSO utilizing PDASC, denoted as SPArcPDASC$\text{SPArc}_{\text{PDASC}}$. Nine clinical cases included five different cancer sites (brain, lung, liver, prostate, and head&neck cancer) were used. The SSO method's performance was evaluated in terms of spot sparsity level (the number of zero-valued elements divided by the total number of elements), beam delivery time, dosimetric plan quality, and plan robustness.ResultsCompared to the SPArcPDASC$\text{SPArc}_{\text{PDASC}}$ plan, the SPArcADMM$\text{SPArc}_{\text{ADMM}}$ plan exhibits superior sparsity and higher delivery efficiency while maintaining good plan quality.ConclusionsThis study introduces a novel spot sparsity optimization approach using the ADMM framework to improve the delivery efficiency of SPArc. Compared to the existing state-of-the-art SSO method, such an approach could further enhance delivery efficiency while maintaining good plan quality, which could promote the implementation of SPArc in the clinic's.
引用
收藏
页码:1789 / 1797
页数:9
相关论文
共 50 条
  • [1] Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy
    Ding, Xuanfeng
    Li, Xiaoqiang
    Zhang, J. Michele
    Kabolizadeh, Peyman
    Stevens, Craig
    Yan, Di
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 1107 - 1116
  • [2] A novel energy layer optimization framework for spot-scanning proton arc therapy
    Gu, Wenbo
    Ruan, Dan
    Lyu, Qihui
    Zou, Wei
    Dong, Lei
    Sheng, Ke
    MEDICAL PHYSICS, 2020, 47 (05) : 2072 - 2084
  • [3] A Novel Energy Layer Optimization Framework for Spot-Scanning Proton Arc Therapy
    Gu, W.
    Ruan, D.
    Lyu, Q.
    Zou, J.
    Dong, L.
    Sheng, K.
    MEDICAL PHYSICS, 2020, 47 (06) : E339 - E339
  • [4] From Concept to First Delivery of the Spot-Scanning Proton Arc Therapy
    Li, X.
    Liu, G.
    Janssens, G.
    De Wilde, O.
    Bossier, V.
    Lerot, X.
    Pouppez, A.
    Yan, D.
    Stevens, C.
    Kabolizadeh, P.
    Ding, X.
    MEDICAL PHYSICS, 2019, 46 (06) : E290 - E290
  • [5] Rotationally Intensified Proton Lattice: A Novel Lattice Technique Using Spot-Scanning Proton Arc Therapy
    Lee, Joseph S.
    Mumaw, Derek A.
    Liu, Peilin
    Loving, Bailey A.
    Sebastian, Ebin
    Cong, Xiaoda
    Stefani, Mark S.
    Loughery, Brian F.
    Li, Xiaoqiang
    Deraniyagala, Rohan
    Almahariq, Muayad F.
    Ding, Xuanfeng
    Quinn, Thomas J.
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (11)
  • [6] Rotationally Intensified Proton Lattice (RIPL): A Novel Lattice Technique Using Spot-Scanning Proton Arc Therapy
    Lee, J. S.
    Mumaw, D.
    Liu, P.
    Loving, B.
    Sebastian, E.
    Ding, X.
    Cong, X.
    Stefani, M.
    Loughery, B.
    Li, X.
    Deraniyagala, R. L., Jr.
    Almahariq, M. F.
    Quinn, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E151 - E152
  • [7] The First Prototype of Spot-Scanning Proton Arc Treatment Delivery
    Li, X.
    Liu, G.
    Janssens, G.
    De Wilde, O.
    Bossier, V.
    Lerot, X.
    Pouppez, A.
    Yan, D.
    Stevens, C. W.
    Kabolizadeh, P.
    Ding, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S242 - S242
  • [8] The first prototype of spot-scanning proton arc treatment delivery
    Li, Xiaoqiang
    Liu, Gang
    Janssens, Guillaume
    De Wilde, Olivier
    Bossier, Vincent
    Lerot, Xavier
    Pouppez, Antoine
    Yan, Di
    Stevens, Craig
    Kabolizadeh, Peyman
    Ding, Xuanfeng
    RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 130 - 136
  • [9] Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence
    Li, Heng
    Zhu, X. Ronald
    Zhang, Xiaodong
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : 547 - 556
  • [10] Spot-scanning proton radiation therapy for intracranial meningiomas
    Weber, DC
    Lomax, AJ
    Rutz, HP
    Pedroni, ES
    Verwey, J
    Goitein, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 97 - 98